Potential new drug class hits multiple cancer cell targets, boosting efficacy and safety
Wednesday, February 1, 2017 - 15:31
in Health & Medicine
A potential new class of anti-cancer drugs inhibits two or more molecular targets at once, maximizing therapeutic efficiency and safety, report scientists.